The clinical efficacy of local ablative treatment for oligometastasis is widely accepted in most cancers. However, due to limited data, this has not been the case for hepatocellular carcinoma (HCC). Here, we report a case of pulmonary oligometastasis of a huge HCC that was treated by multimodality with liver-directed concurrent chemoradiotherapy (CCRT) plus subsequent resection of the primary lesion and local ablative radiotherapy (RT) for subsequent lung oligometastatic lesions. In this patient, liver-directed CCRT induced significant tumor shrinkage with compensatory hypertrophy of the non-tumor liver, followed by curative resection. Surgical resection of the first and second pulmonary metastatic lesions as well as local ablative RT of th...
Cardiac metastasis originating from hepatocellular carcinoma (HCC) is a rare condition with a poor p...
BACKGROUND: For huge hepatocellular carcinoma (HCC), therapeutic decisions have varied from local th...
Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustaine...
Purpose: With respect to various solid cancers, patients with oligometastasis may benefit from local...
PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiother...
There are various methods for treating advanced hepatocellular carcinoma with portal vein invasion, ...
Introduction: Huge hepatocellular carcinoma (HCC) possesses a potential risk for spontaneous rupture...
Hepatocellular cancer (HCC) is increasing dramatically in incidence in Europe and the United States ...
Background: To report our experience with SBRT in primary and secondary liver tumors. Methods: We re...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...
Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer worldwide. The prognosi...
AbstractIntroductionHuge hepatocellular carcinoma (HCC) possesses a potential risk for spontaneous r...
<p><b>Background:</b> The aim of this study was to evaluate the therapeutic outcome of percutaneous ...
AbstractLocal tumor recurrence after thermal ablation of hepatocellular carcinoma (HCC) can impact o...
Objective: Hypofractionated radiotherapy has recently been applied to treat pulmonary metastases of ...
Cardiac metastasis originating from hepatocellular carcinoma (HCC) is a rare condition with a poor p...
BACKGROUND: For huge hepatocellular carcinoma (HCC), therapeutic decisions have varied from local th...
Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustaine...
Purpose: With respect to various solid cancers, patients with oligometastasis may benefit from local...
PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiother...
There are various methods for treating advanced hepatocellular carcinoma with portal vein invasion, ...
Introduction: Huge hepatocellular carcinoma (HCC) possesses a potential risk for spontaneous rupture...
Hepatocellular cancer (HCC) is increasing dramatically in incidence in Europe and the United States ...
Background: To report our experience with SBRT in primary and secondary liver tumors. Methods: We re...
Background: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and treatment options ar...
Hepatocellular carcinoma (HCC) is the third leading cause of death by cancer worldwide. The prognosi...
AbstractIntroductionHuge hepatocellular carcinoma (HCC) possesses a potential risk for spontaneous r...
<p><b>Background:</b> The aim of this study was to evaluate the therapeutic outcome of percutaneous ...
AbstractLocal tumor recurrence after thermal ablation of hepatocellular carcinoma (HCC) can impact o...
Objective: Hypofractionated radiotherapy has recently been applied to treat pulmonary metastases of ...
Cardiac metastasis originating from hepatocellular carcinoma (HCC) is a rare condition with a poor p...
BACKGROUND: For huge hepatocellular carcinoma (HCC), therapeutic decisions have varied from local th...
Introduction Hepatocellular carcinoma (HCC) is rare in non-cirrhotic liver. Achievement of sustaine...